Medical Communications; Regulatory Compliance · medium ·
Pharmaceutical compliance teams need provenance tracking and machine-readable labelling tools for AI-generated medical content under EU rules
The EU AI Act’s Article 50 distinguishes technical marking duties for AI system providers from disclosure duties for certain published content, with relevant exceptions. It is not a blanket labelling mandate for medical text. For pharmaceutical companies, the commercial opening could lie in provenance tracking, scientific source links and expert review workflows that apply the appropriate requirements to each content type.
Part of the Healthcare & Life Sciences Opportunity Outlook, Korim's monthly analysis of emerging opportunities in this sector.